These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 7857202)

  • 21. [Cadmium nephropathy--chornic cadmium poisoning, renal lesions in so-called "Itai-itai" disease, and osteomalacia].
    Saito H; Shitomi K; Hurukawa Y; Shioji R; Furuyama T; Yoshinaga K
    Nihon Rinsho; 1978 Oct; 36(10):3431-8. PubMed ID: 214593
    [No Abstract]   [Full Text] [Related]  

  • 22. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO.
    Mittman N; Sreedhara R; Mushnick R; Chattopadhyay J; Zelmanovic D; Vaseghi M; Avram MM
    Am J Kidney Dis; 1997 Dec; 30(6):912-22. PubMed ID: 9398141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Erythropoietin treatment of anemia associated with multiple myeloma.
    Ludwig H; Fritz E; Kotzmann H; Höcker P; Gisslinger H; Barnas U
    N Engl J Med; 1990 Jun; 322(24):1693-9. PubMed ID: 2342535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology of renal tubular dysfunction in the inhabitants of a cadmium-polluted area in the Jinzu River basin in Toyama Prefecture.
    Aoshima K
    Tohoku J Exp Med; 1987 Jun; 152(2):151-72. PubMed ID: 2442848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severity of tubular brush border damage in cadmium-polluted area (Jinzu river basin): clinical role of urinary trehalase.
    Nakano M; Aoshima K; Katoh T; Teranishi H; Kasuya M; Katoh T
    Environ Res; 1987 Dec; 44(2):161-8. PubMed ID: 3319573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary trehalase activity as an indicator of kidney injury due to environmental cadmium exposure.
    Iwata K; Katoh T; Morikawa Y; Aoshima K; Nishijo M; Teranishi H; Kasuya M
    Arch Toxicol; 1988; 62(6):435-9. PubMed ID: 3074746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of a vitamin D-deficient diet on chronic cadmium exposure in rats.
    Uchida H; Kurata Y; Hiratsuka H; Umemura T
    Toxicol Pathol; 2010 Aug; 38(5):730-7. PubMed ID: 20622193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Itai-itai disease: Lessons from the investigations of environmental epidemiology conducted in the 1970's, with special reference to the studies of the Toyama Institute of Health].
    Aoshima K
    Nihon Eiseigaku Zasshi; 2017; 72(3):149-158. PubMed ID: 28931793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cadmium, osteoporosis and calcium metabolism.
    Kazantzis G
    Biometals; 2004 Oct; 17(5):493-8. PubMed ID: 15688852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. No significant effect of iron deficiency on cadmium body burden or kidney dysfunction among women in the general population in Japan.
    Tsukahara T; Ezaki T; Moriguchi J; Furuki K; Fukui Y; Ukai H; Okamoto S; Sakurai H; Ikeda M
    Int Arch Occup Environ Health; 2003 May; 76(4):275-81. PubMed ID: 12719983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated urinary excretion of metallothionein due to environmental cadmium exposure.
    Tohyama C; Shaikh ZA; Nogawa K; Kobayashi E; Honda R
    Toxicology; 1981; 20(4):289-97. PubMed ID: 7031990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent progress and perspectives in cadmium health effects studies.
    Nomiyama K
    Sci Total Environ; 1980 Apr; 14(3):199-232. PubMed ID: 6771869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythropoietin and inhibitors of in vitro erythropoiesis in the development of anemia in children with renal disease.
    McGonigle RJ; Boineau FG; Beckman B; Ohene-Frempong K; Lewy JE; Shadduck RK; Fisher JW
    J Lab Clin Med; 1985 Apr; 105(4):449-58. PubMed ID: 3981057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary low-molecular-weight proteins in Itai-Itai disease.
    Nomiyama K; Sugata Y; Murata I; Nakagawa S
    Environ Res; 1973 Dec; 6(4):373-81. PubMed ID: 4129634
    [No Abstract]   [Full Text] [Related]  

  • 36. Copper and zinc levels in serum and urine of cadmium-exposed people with special reference to renal tubular damage.
    Nogawa K; Yamada Y; Honda R; Tsuritani I; Kobayashi E; Ishizaki M
    Environ Res; 1984 Feb; 33(1):29-38. PubMed ID: 6363057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Greater potency of darbepoetin-α than erythropoietin in suppression of serum hepcidin-25 and utilization of iron for erythropoiesis in hemodialysis patients.
    Shoji S; Inaba M; Tomosugi N; Okuno S; Ichii M; Yamakawa T; Kurihara S
    Eur J Haematol; 2013 Mar; 90(3):237-44. PubMed ID: 23281632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical evaluation of iron deficiency.
    Cook JD
    Semin Hematol; 1982 Jan; 19(1):6-18. PubMed ID: 6763340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevation of urinary trehalase activity in patients of itai-itai disease.
    Nakano M; Aoshima K; Katoh T; Teranishi H; Kasuya M
    Arch Toxicol; 1987 Jun; 60(4):300-3. PubMed ID: 3307705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
    Chen YC; Hung SC; Tarng DC
    Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.